Testing company LGC expands site at Fordham as part of three-year development plan
PUBLISHED: 14:57 23 November 2017 | UPDATED: 14:57 23 November 2017
A Fordham testing company has completed the next stage of its expansion.
LGC, which tests products for pharmaceutical and biotechnology companies, has added two new 170 square metre laboratories at its Newmarket Road base.
The work, which began in July, is part of a three-year expansion programme which aims to double the number of laboratories and office space as well as bringing in 100 new staff.
Dr Derek Craston, chief scientific officer, said, “We’re really excited about the development and expansion of our Fordham site.
“This investment will initially support our large molecule bioanalysis business, and is part of our ongoing plan to take advantage of our strong analytical capabilities and help us address the needs of customers around the world.
“By investing in this area of our business LGC is very much reinforcing our core vision of ‘Science for a safer world’, and our customers will benefit from integrated analytical and manufacturing solutions spanning lead discovery through to the clinic and beyond.”